Condition
Euthyroid Sick Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
P 3 (1)
P 4 (2)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06660823Phase 3Completed
Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery
NCT06983418CompletedPrimary
Euthyroid Sick Syndrome in Obesity Hypoventilation Syndrome
NCT01501110Phase 4Completed
Effects of N-acetylcysteine on Low T3 Syndrome
NCT01631305Phase 4CompletedPrimary
Levothyroxine for Children With Euthyroid Sick Syndrome
Showing all 4 trials